drugset / Trial / NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Non-randomizedParallel-groupTriple-blindTreatment
Summary
This is a multicenter, long-term extension (LTE) study in participants with ulcerative colitis (UC) from Study SPY123-201 (The SKYLINE-UC study).
Timeline
- Start
- 2026-06-08
- Primary completion
- 2029-03-02
- Completion
- 2030-01-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPY001 | Unknown | — | — |
| Subject | SPY002 | Unknown | — | — |
| Subject | SPY003 | Unknown | — | — |